Antimyosin scintigraphy for detection of cardiac amyloidosis

J Lekakis; M Dimopoulos; J Nanas; V Prassopoulos; N Agapitos; G Alexopoulos; L Palazis; P Kostamis; S Stamatelopoulos; S Moulopoulos

doi:10.1016/s0002-9149(97)00558-4

Antimyosin scintigraphy for detection of cardiac amyloidosis

Am J Cardiol. 1997 Oct 1;80(7):963-5. doi: 10.1016/s0002-9149(97)00558-4.

Authors

J Lekakis¹, M Dimopoulos, J Nanas, V Prassopoulos, N Agapitos, G Alexopoulos, L Palazis, P Kostamis, S Stamatelopoulos, S Moulopoulos

Affiliation

¹ Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece.

PMID: 9382020
DOI: 10.1016/s0002-9149(97)00558-4

Abstract

The diagnostic value of antimyosin scanning in 7 patients with biopsy-proven cardiac amyloidosis was examined in this study. Antimyosin imaging was positive in all amyloid patients, with more intense uptake in patients with heart failure.

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Adult
Amyloidosis / diagnostic imaging*
Antibodies, Monoclonal*
Cardiomyopathies / diagnostic imaging*
Female
Humans
Indium Radioisotopes
Male
Middle Aged
Myosins / immunology*
Prospective Studies
Radionuclide Imaging

Substances

Antibodies, Monoclonal
Indium Radioisotopes
Myosins